Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage i nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection

Journal of Urology

Volumn 186, Issue 4, 2011, Pages 1298-1302

  Nicolai, Nicola ^a   Colecchia, Maurizio ^a   Biasoni, Davide ^a   Catanzaro, Mario ^a   Stagni, Silvia ^a   Torelli, Tullio ^a   Necchi, Andrea ^a   Piva, Luigi ^a   Milani, Angelo ^a   Salvioni, Roberto ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

germ cell and embryonal; lymph node excision; neoplasm invasiveness; neoplasms; testis; vascular tissue

Indexed keywords

CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SURGERY; DIAGNOSTIC TEST ACCURACY STUDY; EMBRYONAL CARCINOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TESTIS TUMOR;

EID: 80052773709     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.05.070     Document Type: Article

References (21)

1. Y. Vergouwe, E.W. Steyerberg, and M.J. Eijkemans Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review J Clin Oncol 21 2003 4092
2. T.K. Choueiri, A.J. Stephenson, and T. Gilligan Management of clinical stage I nonseminomatous germ cell testicular cancer Urol Clin North Am 34 2007 137
3. NCCN Clinical Practice Guidelines in Oncology Testicular Cancer V2.2010. National Comprehensive Cancer Network www.nccn.org Accessed August 20, 2010
4. P. Albers, W. Albrecht, and F. Algaba Guidelines on testicular cancer, updated 2010 European Association of Urology http://www.uroweb.org Accessed November 1, 2010
5. S. Krege, J. Beyer, and R. Souchon European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I Eur Urol 53 2008 478
6. U. De Giorni, N. Nicolai, and S. Tana IGG practice guidelines on germ cell tumor in adult male patients Tumori 94 2008 96
7. T. Tandstad, O. Dahl, and G. Cohn-Cedermark Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA Management Program J Clin Oncol 27 2009 2122
8. S.F. Brewster Challenging the EAU 2009 guidelines on testis cancer: the risk-adapted management of stage I nonseminomatous germ cell tumours: surveillance yields equal results with less toxicity Eur Urol 9 suppl 2010 459
9. C. Kollmannsberger, C. Moore, and K.N. Chi Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy Ann Oncol 21 2010 1296
10. P. Albers, R. Siener, and S. Krege Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group J Clin Oncol 26 2008 2966
11. N. Nicolai, R. Miceli, and R. Artusi A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only J Urol 171 2004 172
12. G. Pizzocaro Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer Eur J Surg Oncol 12 1986 25
13. J.R. Landis, and G.G. Koch An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers Biometrics 33 1977 363
14. I.A. Sesterhenn, R.B. Weiss, and F.K. Mostofi Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study J Clin Oncol 10 1992 69
15. E. Segelov, K.M. Cox, and D. Raghavan The impact of histological review on clinical management of testicular cancer Br J Urol 71 1993 736
16. R.O. Wayment, A. Bourne, and P. Kay Second opinion pathology in tertiary care of patients with urologic malignancies Urol Oncol 29 2011 194
17. D.J. Brenner, R. Doll, and D.T. Goodhead Cancer risks attributable to low doses of ionizing radiation: assessing what we really know Proc Natl Acad Sci USA 100 2003 13761
18. C.T. Nguyen, A.Z. Fu, and T.D. Gilligan Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis J Clin Oncol 28 2010 119
19. J. Sheinfeld, and R.J. Motzer Stage I testicular cancer management and necessity for surgical expertise J Clin Oncol 26 2008 2944
20. N. Nicolai, R. Miceli, and A. Necchi Retroperitoneal lymph-node dissection with no adjuvant chemotherapy in clinical stage I non-seminomatous germ-cell tumours: long-term outcome and analysis of risk factors of recurrence Eur Urol 58 2010 912
21. A.W. van den Belt-Dusebout, R. de Wit, and J.A. Gietema Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 25 2007 4370